Lightspeed Venture Partners

Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases

Retrieved on: 
Wednesday, April 3, 2024
Hereditary hemorrhagic telangiectasia, Telangiectasia, Biotechnology, Blood, Disease, Atlas, Patient, Lung, Stroke, Viking Global Investors, Death, Artery, Chiari malformation, Rupture, Intraparenchymal hemorrhage, Heart failure, Lightspeed Venture Partners, Therapy, TGF, Antibody, Bleeding, Heart, Pharmacology, Unified school district, HHT, PAH, Atlas Venture, Pulmonary hypertension, Pharmaceutical industry

CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched today with $128 million in financing. The Series A was co-led by BVF Partners and Atlas Venture, with participation from Lightspeed Venture Partners, RA Capital Management, Frazier Life Sciences, Viking Global Investors, Velosity Capital, and Checkpoint Capital. Diagonal was co-founded by Chief Executive Officer, Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital. The financing will support further advancement of the company’s proprietary DIAGONAL platform and pipeline of novel therapeutics to value-creating milestones, including its lead program for the treatment of hereditary hemorrhagic telangiectasia (HHT), a severely debilitating bleeding disorder with limited therapeutic options, through clinical proof-of-concept. Diagonal's agonist antibody activates a receptor complex in the TGF-β superfamily genetically impaired in HHT patients. In preclinical models of HHT, Diagonal's agonist antibodies prevent and reverse the formation of pathological vascular malformations.

Key Points: 
  • Diagonal was co-founded by Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital.
  • CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched today with $128 million in financing.
  • Diagonal was co-founded by Chief Executive Officer, Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital.
  • In preclinical models of HHT, Diagonal's agonist antibodies prevent and reverse the formation of pathological vascular malformations.

Glean Appoints Tamar Yehoshua as President, Product and Technology to Accelerate Delivery of Enterprise AI Platform

Retrieved on: 
Tuesday, March 26, 2024
Software, Data Analytics, Artificial Intelligence, Data Management, Professional Services, Technology, Apps, Applications, Security, Microsoft, Organization, Pressure, Documentation, Citigroup, Software as a service, Growth, Data science, RAG, Knowledge, Meta, Research, Blog, Slack, ICONIQ, Lightspeed Venture Partners, Love, Ecosystem, Uber, IVP, Sequoia Capital, Sales

Glean , the AI-powered work assistant making waves among CIOs under pressure to quickly and securely deploy generative AI in the enterprise, announced Tamar Yehoshua as the company’s first President of Product and Technology, effective March 11.

Key Points: 
  • Glean , the AI-powered work assistant making waves among CIOs under pressure to quickly and securely deploy generative AI in the enterprise, announced Tamar Yehoshua as the company’s first President of Product and Technology, effective March 11.
  • She will oversee all of research and development, including global engineering, product, design, and data science, as Glean enters a period of rapid growth.
  • “Glean has seen tremendous growth over the last year as we help more and more companies bring secure, responsible generative AI into their organizations,” said Arvind Jain, co-founder and CEO of Glean.
  • “I loved working in venture capital, but the opportunity to lead product and technology at Glean was too good to pass up,” said Tamar Yehoshua.

Foundry Raises $80 Million in Seed and Series A Funding to Build a New Breed of Public Cloud

Retrieved on: 
Thursday, March 21, 2024
Internet, Data Management, Technology, Artificial Intelligence, Software, Deep learning, Computational biology, GPU, LG, Speed of light, MIT, Databricks, Pear VC, AI, Stanford University, Conviction, Civilization, M12 (venture capital), Lightspeed Venture Partners, Ecosystem, NEA, KKR, Economics, Sequoia Capital

Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.

Key Points: 
  • Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.
  • Foundry is building to ensure humanity maximizes the utility of the computing power we already have, and will produce.
  • Foundry’s innovative methods are solving these issues by providing scalable GPU instances with unmatched price-performance ratios.
  • If you are interested in becoming a customer or partner, or joining the team, please visit the company’s website .

Big Sur AI raises $6.9M and launches an AI Sales Agent for E-commerce Merchants

Retrieved on: 
Wednesday, March 13, 2024
Online Retail, Retail, Technology, Software, Electronic Commerce, Artificial Intelligence, Speed of light, Entrepreneurship, Noise, Environment, CFO, Shopify, Meta, Google Shopping, AI, Android, Advertising, Lightspeed Venture Partners, CMO, Marketing, Online shopping

Today, Big Sur AI , an AI platform for e-commerce, announced a $6.9M seed round to democratize and simplify access to AI for retailers and brands.

Key Points: 
  • Today, Big Sur AI , an AI platform for e-commerce, announced a $6.9M seed round to democratize and simplify access to AI for retailers and brands.
  • Retail will be one of the biggest beneficiaries of AI transformation1 and Big Sur AI is dedicated to ensuring every merchant can easily tap into these benefits.
  • Big Sur AI is making that kind of customer relationship automatic.”
    The company’s AI Sales Agent, which is tailored for each merchant, is aimed at boosting merchants' sales through higher conversion rates and larger order sizes, while enabling shoppers to make well-informed purchase decisions effortlessly.
  • They saw firsthand the enormous opportunity to redefine the merchant and shopper experience for the AI era and started Big Sur AI to ensure that these advancements benefit all merchants.

MAPLIGHT THERAPEUTICS APPOINTS MARIA WALKER TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, April 3, 2024
KPMG, Entrepreneurship, Health, Patient, SAN, CNS, University, MD, Audit committee, MBA, Neuropsychiatry, Lightspeed Venture Partners, Therapy, Economics, Management

SAN FRANCISCO and BOSTON, April 3, 2024 /PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating central nervous system (CNS) disorders, today announced the appointment of Maria Walker to its Board of Directors and audit committee. Ms. Walker brings more than 30 years of experience working with public and private companies across a variety of sectors, including healthcare, technology, venture capital and private equity.

Key Points: 
  • Walker brings 30+ years of investment, operational, and advisory experience
    SAN FRANCISCO and BOSTON, April 3, 2024 /PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating central nervous system (CNS) disorders, today announced the appointment of Maria Walker to its Board of Directors and audit committee.
  • "We are thrilled to welcome Maria Walker to MapLight's board of directors," Christopher Kroeger, MD, MBA, MapLight CEO.
  • "We are thrilled to welcome Maria to MapLight's board," said Christopher Kroeger, M.D., MBA, MapLight's Chief Executive Officer and Co-Founder.
  • Ms. Walker also served as Audit Committee Chairman of ForgeRock and as Chief Financial Officer of Montes Archimedes Acquisition Corp.
    "This is an exciting time for MapLight and neuropsychiatry," said Ms. Walker.

Axonius Announces $200 Million Series E Extension Amid Explosive Growth

Retrieved on: 
Tuesday, March 5, 2024
Schneider Electric, Stripe, Defense, SMP, Risk, News Corp, AB InBev, ARR, Lightspeed Venture Partners, Accel, Software as a service, Organization, Software, Cryptocurrency

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Axonius, the leader in cybersecurity asset management and SaaS management, today announced it has secured $200 million in a Series E extension funding round led by Accel and Lightspeed Venture Partners. Existing investor Stripes also participated. This new round of funding is intended to accelerate innovation and scale across the globe as demand for the Axonius Platform continues to grow. The company crossed $100 million in annual recurring revenue in 2023 as it continues to expand its customer base, which includes more than a dozen of the Fortune 500 and global organizations such as Schneider Electric, News Corp, and Anheuser-Busch InBev. The company also supports four of the five major U.S. Department of Defense service agencies.

Key Points: 
  • NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Axonius, the leader in cybersecurity asset management and SaaS management , today announced it has secured $200 million in a Series E extension funding round led by Accel and Lightspeed Venture Partners.
  • This new round of funding is intended to accelerate innovation and scale across the globe as demand for the Axonius Platform continues to grow.
  • "Axonius has gone from zero revenue to exceeding $100 million in ARR in just 4.5 years, making us one of the fastest growing cybersecurity companies,” said Dean Sysman, CEO and Co-founder at Axonius.
  • The more integrations, the more information Axonius can surface about security gaps, risk, misconfigurations, cost inefficiencies, and more.

Intenseye Secures Record-breaking $64M Series B to Advance Its Mission of Transforming Workplace Safety With AI

Retrieved on: 
Tuesday, February 27, 2024
Technology, Human Resources, Professional Services, Audio, Video, Software, Hardware, Data Analytics, Data Management, Artificial Intelligence, International Labour Organization, AI, American Industrial Hygiene Association, Gen, Intelligence, Digital, Safety, Health, Lightspeed Venture Partners, EHS, Insight Partners, Environmental health, Privacy, Speed of light, Accident, Medical device

“Our commitment to the ethical AI principle of privacy-by-design sets us apart, helping shield workers’ psychological safety while providing unparalleled protection for their physical safety,” added Esen.

Key Points: 
  • “Our commitment to the ethical AI principle of privacy-by-design sets us apart, helping shield workers’ psychological safety while providing unparalleled protection for their physical safety,” added Esen.
  • The company's core AI platform addresses a fundamental pain point across a wide range of industries – we're so excited to partner with them and support their mission to transform workplace safety."
  • By building on top of existing but under-utilized camera investments, Intenseye adds 24/7 safety intelligence that drives measurable change in the service of workforces worldwide.
  • We’re proud to have supported Sercan and his team from day one of their journey.”
    For more information on Intenseye’s AI-powered workplace safety solutions, visit www.intenseye.com/ .

Glean Announces Over $200M Series D to Accelerate Secure Deployment of Generative AI in the Enterprise

Retrieved on: 
Tuesday, February 27, 2024
Professional Services, Data Management, Technology, Data Analytics, Software, Artificial Intelligence, RAG, Knowledge management, Pressure, Sony, Uber, Documentation, Lightspeed Venture Partners, Meta, IVP, Software as a service, Organization, ICONIQ, Ecosystem, Sequoia Capital, Citigroup, Speed of light, Knowledge, BILL, Microsoft, Sales

The funding will accelerate Glean’s momentum as it meets sharp customer demand from enterprises and as companies race to implement generative AI in their businesses.

Key Points: 
  • The funding will accelerate Glean’s momentum as it meets sharp customer demand from enterprises and as companies race to implement generative AI in their businesses.
  • Founded by former Google search engineers in 2019, Glean started as a turnkey enterprise search and knowledge management solution connecting to over 100 SaaS apps.
  • Most recently, Glean introduced its low-code and no-code centralized AI platform, allowing companies to build custom generative AI experiences grounded in their company knowledge.
  • A recent survey of CIOs by Glean found that 78 percent of respondents believe generative AI will be critical to their organization’s productivity.

Abridge Emerges as a Healthcare AI Leader, Raising $150M to Accelerate R&D

Retrieved on: 
Friday, February 23, 2024
Health, Technology, Hospitals, Health Technology, Software, General Health, Artificial Intelligence, EMR, Caregiver, Spark Capital, Artificial intelligence in healthcare, Multimedia, AI, Investment, Computer, Redpoint Ventures, Massachusetts General Hospital, Nuance Communications, Documentation, Series, Lightspeed Venture Partners, IVP, Associate, Patient, Speech, Union Square Ventures, Carnegie Mellon University, Research, Medical device

This raise comes just 4 months after their $30M Series B , and is one of the largest funding rounds made to date in generative AI for healthcare.

Key Points: 
  • This raise comes just 4 months after their $30M Series B , and is one of the largest funding rounds made to date in generative AI for healthcare.
  • Today, Abridge also announced a new enterprise agreement with the Yale New Haven Health System, the largest and most comprehensive healthcare system in Connecticut, that will give thousands of clinicians access to Abridge for clinical documentation.
  • Yale New Haven Health has selected Abridge as their generative AI partner in this area of ambient listening.
  • CTO Zack Lipton , a widely cited Associate Professor at Carnegie Mellon and pioneer in responsible AI research, has assembled the strongest research team in healthcare AI.

Webull Corporation, a Leading Digital Investment Platform, to Publicly List Through Business Combination with SK Growth Opportunities Corporation (NASDAQ: SKGR)

Retrieved on: 
Wednesday, February 28, 2024
Acquisition, Prospectus, Register, Form F-4, Growth, Digital, Transaction, General Atlantic, Form, Local, Coatue Management, Fintech, Lightspeed Venture Partners, Kirkland & Ellis, Professional corporation, Business analyst, LLP, Corporation, Partnership, Cryptocurrency

Webull is a leading digital investment platform built upon a next-generation, global infrastructure.

Key Points: 
  • Webull is a leading digital investment platform built upon a next-generation, global infrastructure.
  • Webull launched in the United States in 2018 and has since expanded to Asia Pacific, Europe and Latin America.
  • Today, the Webull App has been downloaded more than 40 million times and has 20 million registered users globally.
  • "The business combination with SK Growth marks a significant milestone for Webull.